share_log

京新药业(002020.SZ)发布前三季度业绩,净利润5.75亿元,同比增长21.66%

Zhejiang Jingxin Pharmaceutical (002020.SZ) released its performance for the first three quarters, with a net income of 0.575 billion yuan, a year-on-year increase of 21.66%.

Zhitong Finance ·  Oct 24 05:22

Zhejiang Jingxin Pharmaceutical (002020.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...

According to the Finance and Economics App, Zhejiang Jingxin Pharmaceutical (002020.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 3.209 billion yuan, a year-on-year increase of 9.68%. The net income attributable to the shareholders of the listed company was 0.575 billion yuan, an increase of 21.66% year-on-year. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.494 billion yuan, an increase of 13.16% year-on-year.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment